On 2015 Jun 28, Erick H Turner commented:

Below is a list of DOIs and links to the FDA review documents used in the writing of this article (of which I was lead author):

doi:10.6083/M4R2102M Aripiprazole medical review http://digitalcommons.ohsu.edu/fdadrug/1 doi:10.6083/M4M907BW Aripiprazole medical review http://digitalcommons.ohsu.edu/fdadrug/2 doi:10.6083/M4GH9GN2 Aripiprazole statistical review http://digitalcommons.ohsu.edu/fdadrug/3

doi:10.6083/M4BV7F9M Iloperidone administrative correspondence http://digitalcommons.ohsu.edu/fdadrug/4 doi:10.6083/M4736PMN Iloperidone approval letter http://digitalcommons.ohsu.edu/fdadrug/5 doi:10.6083/M43B5XVG Iloperidone medical review http://digitalcommons.ohsu.edu/fdadrug/6 doi:10.6083/M4ZK5FCK Iloperidone statistical review http://digitalcommons.ohsu.edu/fdadrug/7 doi:10.6083/M4TT4PNV Iloperidone summary review (Division Director) http://digitalcommons.ohsu.edu/fdadrug/8 doi:10.6083/M4Q23XXF Iloperidone not approvable letter http://digitalcommons.ohsu.edu/fdadrug/9 doi:10.6083/M4K9367Z Iloperidone Office Director memo http://digitalcommons.ohsu.edu/fdadrug/10

doi:10.6083/M4FN14W3 Olanzapine complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/11

doi:10.6083/M49W0D67 Paliperidone statistical review http://digitalcommons.ohsu.edu/fdadrug/12 doi:10.6083/M4639NFT Paliperidone medical review http://digitalcommons.ohsu.edu/fdadrug/13

doi:10.6083/M42B8WQ3 Quetiapine statistical review http://digitalcommons.ohsu.edu/fdadrug/14 doi:10.6083/M4XK8D76 Quetiapine medical review http://digitalcommons.ohsu.edu/fdadrug/15

doi:10.6083/M4ST7NHG Risperidone Consta complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/16 doi:10.6083/M4DN43RQ Risperidone immediate release complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/19

doi:10.6083/M4P26WTH Ziprasidone statistical review http://digitalcommons.ohsu.edu/fdadrug/17 doi:10.6083/M4JD4VG2 Ziprasidone medical review http://digitalcommons.ohsu.edu/fdadrug/18

On 2015 Jun 28, Erick H Turner commented:

Below is a list of DOIs and links to the FDA review documents used in the writing of this article (of which I was lead author):

doi:10.6083/M4R2102M Aripiprazole medical review http://digitalcommons.ohsu.edu/fdadrug/1 doi:10.6083/M4M907BW Aripiprazole medical review http://digitalcommons.ohsu.edu/fdadrug/2 doi:10.6083/M4GH9GN2 Aripiprazole statistical review http://digitalcommons.ohsu.edu/fdadrug/3

doi:10.6083/M4BV7F9M Iloperidone administrative correspondence http://digitalcommons.ohsu.edu/fdadrug/4 doi:10.6083/M4736PMN Iloperidone approval letter http://digitalcommons.ohsu.edu/fdadrug/5 doi:10.6083/M43B5XVG Iloperidone medical review http://digitalcommons.ohsu.edu/fdadrug/6 doi:10.6083/M4ZK5FCK Iloperidone statistical review http://digitalcommons.ohsu.edu/fdadrug/7 doi:10.6083/M4TT4PNV Iloperidone summary review (Division Director) http://digitalcommons.ohsu.edu/fdadrug/8 doi:10.6083/M4Q23XXF Iloperidone not approvable letter http://digitalcommons.ohsu.edu/fdadrug/9 doi:10.6083/M4K9367Z Iloperidone Office Director memo http://digitalcommons.ohsu.edu/fdadrug/10

doi:10.6083/M4FN14W3 Olanzapine complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/11

doi:10.6083/M49W0D67 Paliperidone statistical review http://digitalcommons.ohsu.edu/fdadrug/12 doi:10.6083/M4639NFT Paliperidone medical review http://digitalcommons.ohsu.edu/fdadrug/13

doi:10.6083/M42B8WQ3 Quetiapine statistical review http://digitalcommons.ohsu.edu/fdadrug/14 doi:10.6083/M4XK8D76 Quetiapine medical review http://digitalcommons.ohsu.edu/fdadrug/15

doi:10.6083/M4ST7NHG Risperidone Consta complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/16 doi:10.6083/M4DN43RQ Risperidone immediate release complete Drug Approval Package (all reviews) http://digitalcommons.ohsu.edu/fdadrug/19

doi:10.6083/M4P26WTH Ziprasidone statistical review http://digitalcommons.ohsu.edu/fdadrug/17 doi:10.6083/M4JD4VG2 Ziprasidone medical review http://digitalcommons.ohsu.edu/fdadrug/18